Febrile neutropenia/antifungal drug trial design
Executive Summary
FDA will hold a public workshop on clinical trial design for febrile neutropenia and antifungal combination therapies on Sept. 4. The meeting, co-sponsored by the National Institute of Allergy & Infectious Diseases, will take place at the Hyatt Regency in Bethesda, Md., beginning at 1 p.m. [To view a webcast or live videoconference of this meeting, contact [email protected] or call 800-332-1370 ext. 7210]...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.